{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:09:44Z","timestamp":1768316984445,"version":"3.49.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"7","funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R25DA037190"],"award-info":[{"award-number":["R25DA037190"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R25DA035692"],"award-info":[{"award-number":["R25DA035692"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA013911"],"award-info":[{"award-number":["T32DA013911"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"DOI":"10.1093\/cid\/cix493","type":"journal-article","created":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T19:12:46Z","timestamp":1495653166000},"page":"1247-1248","source":"Crossref","is-referenced-by-count":6,"title":["Long-Acting Injectable Antiretroviral Therapy: An Opportunity to Improve Human Immunodeficiency Virus (HIV) Treatment and Reduce HIV Transmission Among Persons Being Released From Prison Facilities"],"prefix":"10.1093","volume":"65","author":[{"given":"Lauren","family":"Brinkley-Rubinstein","sequence":"first","affiliation":[{"name":"Department of Social Medicine,"},{"name":"Center for Health Equity Research, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L","family":"Rosen","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Christopher","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Human Behavior, Brown University,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauri","family":"Bazerman","sequence":"additional","affiliation":[{"name":"The Miriam Hospital, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curt G","family":"Beckwith","sequence":"additional","affiliation":[{"name":"The Miriam Hospital, and"},{"name":"Division of Infectious Diseases, Warren Alpert Medical School, Brown University, Providence, Rhode Island"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,5,26]]},"reference":[{"key":"key\n\t\t\t\t20180306233527_CIT0001","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(11)60821-0","article-title":"Treatment as prevention\u2014a double hat-trick","volume":"378","author":"Montaner","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306233527_CIT0002","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.2105\/AJPH.2015.302635","article-title":"The HIV care cascade before, during, and after incarceration: a systematic review and data synthesis","volume":"105","author":"Iroh","year":"2015","journal-title":"Am J Public Health"},{"key":"key\n\t\t\t\t20180306233527_CIT0003","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/cid\/cir491","article-title":"Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy","volume":"53","author":"Westergaard","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306233527_CIT0004","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/infdis\/jir032","article-title":"Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users","volume":"203","author":"Milloy","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306233527_CIT0005","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamainternmed.2014.601","article-title":"Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate","volume":"174","author":"Meyer","year":"2014","journal-title":"JAMA Intern Med"},{"key":"key\n\t\t\t\t20180306233527_CIT0006","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1086\/421392","article-title":"Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community","volume":"38","author":"Springer","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306233527_CIT0007","volume-title":"HIV in prisons, 2001\u20132010","author":"Maruschak"},{"key":"key\n\t\t\t\t20180306233527_CIT0008","doi-asserted-by":"crossref","first-page":"e7558","DOI":"10.1371\/journal.pone.0007558","article-title":"HIV\/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity","volume":"4","author":"Spaulding","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180306233527_CIT0009","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/COH.0000000000000167","article-title":"Extending access with long-acting antiretroviral therapy: the next advance in HIV-1 therapeutics and prevention","volume":"10","author":"Markowitz","year":"2015","journal-title":"Curr Opin HIV AIDS"},{"key":"key\n\t\t\t\t20180306233527_CIT0010","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0002-9378(12)91813-X","article-title":"Long-acting injectable contraception with depot medroxyprogesterone acetate","volume":"170","author":"Kaunitz","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20180306233527_CIT0011","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1176\/appi.ajp.160.6.1125","article-title":"Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic","volume":"160","author":"Kane","year":"2003","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180306233527_CIT0012","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306233527_CIT0013","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/QCO.0000000000000214","article-title":"Delivery of long-acting injectable antivirals: best approaches and recent advances","volume":"28","author":"Hickey","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20180306233527_CIT0014","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/COH.0000000000000002","article-title":"Long-acting injectable antiretrovirals for HIV treatment and prevention","volume":"8","author":"Spreen","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"key\n\t\t\t\t20180306233527_CIT0015","unstructured":"Margolis DA , Brinson CC, Smith GH Cabotegravir and rilpivirine as 2-drug oral maintenance therapy: LATTE W96 results [abstract 554LB]. In: Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, WA, 2015."},{"key":"key\n\t\t\t\t20180306233527_CIT0016","unstructured":"Margolis D , Podzamczer D, Stellbrinks HJ Cabotegravir + rilpivirine as long-acting maintenance therapy: LATTE-2 week 48 results [abstract THAB0206LB]. In: 21st International AIDS Conference, Durban, South Africa, 2016."},{"key":"key\n\t\t\t\t20180306233527_CIT0017","unstructured":"Kerrigan D , MantsiosA, MargolisD, MurryM. Experiences with long-acting injectable ART: a qualitative study among people living with HIV participating in a phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain [abstract THAB0204]. In: 21st International AIDS Conference, Durban, South Africa, 2016."}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/65\/7\/1247\/24267240\/cix493.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T12:12:46Z","timestamp":1602159166000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/65\/7\/1247\/3854985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,26]]},"references-count":17,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,5,26]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix493","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10,1]]},"published":{"date-parts":[[2017,5,26]]}}}